Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tie2 activation protects against prothrombotic endothelial dysfunction in COVID-19
Alec A. Schmaier, Gabriel Pajares Hurtado, Zachary Manickas-Hill, et al.
JCI Insight (2021) Vol. 6, Iss. 20
Open Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

Vasculopathy in COVID-19
Robert Flaumenhaft, Keiichi Enjyoji, Alec A. Schmaier
Blood (2022) Vol. 140, Iss. 3, pp. 222-235
Open Access | Times Cited: 98
Combining L-Arginine with vitamin C improves long-COVID symptoms: The LINCOLN Survey
Raffaele Izzo, Valentina Trimarco, Pasquale Mone, et al.
Pharmacological Research (2022) Vol. 183, pp. 106360-106360
Open Access | Times Cited: 75
Targeting protein phosphatases in cancer immunotherapy and autoimmune disorders
Stephanie M. Stanford, Nunzio Bottini
Nature Reviews Drug Discovery (2023) Vol. 22, Iss. 4, pp. 273-294
Open Access | Times Cited: 74
Endotheliopathy in Acute COVID-19 and Long COVID
Alice G. Vassiliou, Charikleia S. Vrettou, Chrysi Keskinidou, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 9, pp. 8237-8237
Open Access | Times Cited: 33
Possibility of Using NO Modulators for Pharmacocorrection of Endothelial Dysfunction After Prenatal Hypoxia
И. Ф. Беленичев, Olena Popazova, Oleh Yadlovskyi, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 106-106
Open Access | Times Cited: 1
Exosomal miR-145 and miR-885 Regulate Thrombosis in COVID-19
Jessica Gambardella, Urna Kansakar, Celestino Sardu, et al.
Journal of Pharmacology and Experimental Therapeutics (2022) Vol. 384, Iss. 1, pp. 109-115
Open Access | Times Cited: 38
Vascular Endothelial Glycocalyx Damage and Potential Targeted Therapy in COVID-19
Duoduo Zha, Mingui Fu, Yisong Qian
Cells (2022) Vol. 11, Iss. 12, pp. 1972-1972
Open Access | Times Cited: 34
Inflammation and vascular remodeling in COVID-19 hearts
Christopher Werlein, Maximilian Ackermann, Helge Stark, et al.
Angiogenesis (2022) Vol. 26, Iss. 2, pp. 233-248
Open Access | Times Cited: 30
Heparan sulfate mimetic fucoidan restores the endothelial glycocalyx and protects against dysfunction induced by serum of COVID-19 patients in the intensive care unit
Lushun Yuan, Shuzhen Cheng, Wendy Sol, et al.
ERJ Open Research (2022) Vol. 8, Iss. 2, pp. 00652-2021
Open Access | Times Cited: 29
A machine learning algorithm for peripheral artery disease prognosis using biomarker data
Ben Li, Farah Shaikh, Abdelrahman Zamzam, et al.
iScience (2024) Vol. 27, Iss. 3, pp. 109081-109081
Open Access | Times Cited: 8
Endothelial cell activation, Weibel-Palade body secretion, and enhanced angiogenesis in severe COVID-19
Ellie Karampini, Helen Fogarty, Stephanie Elliott, et al.
Research and Practice in Thrombosis and Haemostasis (2023) Vol. 7, Iss. 2, pp. 100085-100085
Open Access | Times Cited: 14
Designer high-density lipoprotein particles enhance endothelial barrier function and suppress inflammation
Yueh‐Chien Lin, Steven Swendeman, Irina S. Moreira, et al.
Science Signaling (2024) Vol. 17, Iss. 824
Open Access | Times Cited: 6
Fundamentals in Covid-19-Associated Thrombosis: Molecular and Cellular Aspects
Daniella M. Mizurini, Eugênio D. Hottz, Patrı́cia T. Bozza, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 30
Angiopoietin 2 Is Associated with Vascular Necroptosis Induction in Coronavirus Disease 2019 Acute Respiratory Distress Syndrome
David R. Price, Elisa Benedetti, Eric A. Hoffman, et al.
American Journal Of Pathology (2022) Vol. 192, Iss. 7, pp. 1001-1015
Open Access | Times Cited: 20
Angiopoietin-2 Inhibition of Thrombomodulin-Mediated Anticoagulation—A Novel Mechanism That May Contribute to Hypercoagulation in Critically Ill COVID-19 Patients
Michael Hultström, Karin Fromell, Anders Larsson, et al.
Biomedicines (2022) Vol. 10, Iss. 6, pp. 1333-1333
Open Access | Times Cited: 20
Role of Angiopoietin-Tie axis in vascular and lymphatic systems and therapeutic interventions
Rui Wang, Moua Yang, Longguang Jiang, et al.
Pharmacological Research (2022) Vol. 182, pp. 106331-106331
Closed Access | Times Cited: 20
SARS‐CoV‐2 infection results in upregulation of Plasminogen Activator Inhibitor‐1 and Neuroserpin in the lungs, and an increase in fibrinolysis inhibitors associated with disease severity
Kevin H. Toomer, Gloria F. Gerber, Yifan Zhang, et al.
eJHaem (2023) Vol. 4, Iss. 2, pp. 324-338
Open Access | Times Cited: 12
COVID-19 and Pulmonary Angiogenesis: The Possible Role of Hypoxia and Hyperinflammation in the Overexpression of Proteins Involved in Alveolar Vascular Dysfunction
Anna Flavia Ribeiro Santos Miggiolaro, Felipe Silva, David Batista Wiedmer, et al.
Viruses (2023) Vol. 15, Iss. 3, pp. 706-706
Open Access | Times Cited: 12
miR-142 Targets TIM-1 in Human Endothelial Cells: Potential Implications for Stroke, COVID-19, Zika, Ebola, Dengue, and Other Viral Infections
Urna Kansakar, Jessica Gambardella, Fahimeh Varzideh, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10242-10242
Open Access | Times Cited: 18
Angiopoietins/Tie2 signaling axis and its role in angiogenesis of psoriasis
Jiao Li, Hui Hou, Junqin Li, et al.
Acta Histochemica (2025) Vol. 127, Iss. 1, pp. 152228-152228
Closed Access
Open Source Repurposing Reveals Broad-Spectrum Antiviral Activity of Diphenylureas
Ulrich Betz, Robert Garces, Norbert Beier, et al.
Viruses (2025) Vol. 17, Iss. 3, pp. 385-385
Open Access
Enhanced prediction of thrombotic events in hospitalized COVID-19 patients with soluble thrombomodulin
Sergio Padilla, María Andreo Galera, Pascual Marco, et al.
PLoS ONE (2025) Vol. 20, Iss. 3, pp. e0319666-e0319666
Open Access
Persistence of inflammatory and vascular mediators 5 months after hospitalization with COVID-19 infection
J. Mark Melhorn, Asma Alamoudi, Alexander J. Mentzer, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 7
Temporal transcriptomic analysis using TrendCatcher identifies early and persistent neutrophil activation in severe COVID-19
Xinge Wang, Mark A. Sanborn, Yang Dai, et al.
JCI Insight (2022) Vol. 7, Iss. 7
Open Access | Times Cited: 12
Coronavirus Disease (COVID)-19 and Diabetic Kidney Disease
Swayam Prakash Srivastava, Arvind K. Srivastava, Subhash Chand, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 8, pp. 751-751
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top